Adlina Tablet 5 mg contains Linagliptin 5 mg, an oral antidiabetic medication used for the management of type 2 diabetes mellitus. It belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels by enhancing the body’s natural ability to control glucose. Adlina is prescribed for adults whose blood glucose levels are not adequately controlled with diet, exercise, and lifestyle modifications alone.

Adlina can be used as monotherapy or in combination with other antidiabetic agents, such as metformin or insulin, to achieve better glycemic control. It is a convenient once-daily tablet, making it easier for patients to adhere to their diabetes management plan.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Linagliptin 5 mg

Mechanism of Action

Linagliptin, the active ingredient in Adlina, works by inhibiting the enzyme DPP-4. This enzyme normally breaks down incretin hormones, such as GLP-1 and GIP, which are responsible for stimulating insulin release in response to meals and suppressing glucagon secretion. By inhibiting DPP-4:

• Insulin secretion increases when blood glucose is elevated.

• Glucagon levels decrease, reducing excess glucose production by the liver.

• Postprandial (after-meal) and fasting blood glucose levels are improved.

This mechanism allows Adlina to control blood sugar without directly causing insulin overproduction, minimizing the risk of hypoglycemia when used alone.

Indications

Adlina Tablet 5 mg is indicated for:

• Management of Type 2 Diabetes Mellitus

• Adults inadequately controlled with diet and exercise alone

• Monotherapy in patients intolerant to other oral antidiabetic medications

• Combination therapy with metformin, sulfonylureas, SGLT2 inhibitors, or insulin for enhanced glycemic control

Benefits

• Effective Glycemic Control: Helps reduce both fasting and postprandial blood glucose levels.

• Improved HbA1c: Supports long-term blood sugar management.

• Low Hypoglycemia Risk: Minimal risk when used as monotherapy due to glucose-dependent action.

• Weight Neutral: Unlike some antidiabetic drugs, Linagliptin does not cause weight gain.

• Convenient Dosing: Once-daily tablet improves patient compliance.

• Combination Therapy Flexibility: Can be safely combined with other diabetes medications under medical supervision.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Dosage and Administration

Adlina Tablet 5 mg is usually taken once daily, with or without food. The exact dosage and treatment plan should be determined by a healthcare professional based on the patient’s blood glucose levels, response to therapy, and other health conditions.

Regular monitoring of blood sugar levels and periodic HbA1c testing are recommended to evaluate treatment effectiveness.

Safety and Precautions

• Not indicated for Type 1 diabetes or diabetic ketoacidosis.

• Patients with kidney or liver impairment should use Adlina under medical supervision, although dose adjustment is usually not required.

• Rare side effects may include mild headache, nasopharyngitis, or gastrointestinal discomfort.

• If used in combination with insulin or sulfonylureas, the risk of hypoglycemia may increase.

• Patients should inform their healthcare provider about other medications and medical conditions before starting treatment.